Eric A. Klein, MD has been appointed chairman of the Glickman Urological and Kidney Institute at the Cleveland Clinic.
Eric A. Klein, MD has been appointed chairman of the Glickman Urological and Kidney Institute at Cleveland Clinic.
Dr. Klein, a leader in the biology and management of prostate cancer, served as interim chair of the institute following the death of previous chairman Andrew Novick, MD in October 2008. His clinical area of interest is urologic oncology, including cancers of the prostate, bladder, testis, and kidney.
“As a national and international expert in his field, Eric is well-positioned to further expand the institute’s reputation for medical and surgical advancements while fostering an environment of collaboration,” said Joseph Hahn, MD, Cleveland Clinic chief of staff. “Eric brings a wealth of medical and research experience and expertise to this position, which will benefit the highly ranked Glickman Urological and Kidney Institute.”
From evidence to practice: Dr. Makarov discusses implementation science in urology
July 25th 2024“What our major contribution is, I think as urologists doing implementation science, is determining the important questions, which we are particularly well-suited to do because we're taking care of the patients,” says Danil V. Makarov, MD, MHS.